Business Description
DHG Pharmaceutical JSC
NAICS : 325412
ISIN : VN000000DHG0
Compare
Compare
Traded in other countries / regions
DHG.Vietnam IPO Date
2006-12-01Description
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.34 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.76 | |||||
Interest Coverage | 32.73 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 6.41 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year EBITDA Growth Rate | 11.4 | |||||
3-Year EPS without NRI Growth Rate | 12.7 | |||||
3-Year Book Growth Rate | 10.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.29 | |||||
9-Day RSI | 37.36 | |||||
14-Day RSI | 37.23 | |||||
6-1 Month Momentum % | 3.04 | |||||
12-1 Month Momentum % | -3.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.57 | |||||
Quick Ratio | 1.81 | |||||
Cash Ratio | 1.48 | |||||
Days Inventory | 191.02 | |||||
Days Sales Outstanding | 34.5 | |||||
Days Payable | 32.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 7.02 | |||||
Dividend Payout Ratio | 0.64 | |||||
3-Year Dividend Growth Rate | -7.9 | |||||
Forward Dividend Yield % | 7.02 | |||||
5-Year Yield-on-Cost % | 14.62 | |||||
Shareholder Yield % | 4.09 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.57 | |||||
Operating Margin % | 17.64 | |||||
Net Margin % | 16.83 | |||||
FCF Margin % | 9 | |||||
ROE % | 18.13 | |||||
ROA % | 13.93 | |||||
ROIC % | 26.39 | |||||
ROC (Joel Greenblatt) % | 38.41 | |||||
ROCE % | 20.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.09 | |||||
Forward PE Ratio | 14.72 | |||||
PE Ratio without NRI | 17.11 | |||||
Shiller PE Ratio | 16.71 | |||||
Price-to-Owner-Earnings | 18.22 | |||||
PEG Ratio | 1.78 | |||||
PS Ratio | 2.83 | |||||
PB Ratio | 3.27 | |||||
Price-to-Tangible-Book | 3.42 | |||||
Price-to-Free-Cash-Flow | 31.03 | |||||
Price-to-Operating-Cash-Flow | 18.28 | |||||
EV-to-EBIT | 12.46 | |||||
EV-to-Forward-EBIT | 11.4 | |||||
EV-to-EBITDA | 11.31 | |||||
EV-to-Forward-EBITDA | 10.6 | |||||
EV-to-Revenue | 2.42 | |||||
EV-to-Forward-Revenue | 2.43 | |||||
EV-to-FCF | 26.84 | |||||
Price-to-Projected-FCF | 1.5 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.72 | |||||
Price-to-Graham-Number | 1.61 | |||||
Price-to-Net-Current-Asset-Value | 4.96 | |||||
Price-to-Net-Cash | 17.17 | |||||
Earnings Yield (Greenblatt) % | 8.03 | |||||
FCF Yield % | 3.22 | |||||
Forward Rate of Return (Yacktman) % | 13.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DHG Pharmaceutical JSC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚«) | 4,998,537.799 | ||
EPS (TTM) (â‚«) | 6224.24 | ||
Beta | 0 | ||
Volatility % | 20.74 | ||
14-Day RSI | 37.23 | ||
14-Day ATR (â‚«) | 1683.586616 | ||
20-Day SMA (â‚«) | 108925 | ||
12-1 Month Momentum % | -3.2 | ||
52-Week Range (â‚«) | 95000 - 125900 | ||
Shares Outstanding (Mil) | 130.75 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DHG Pharmaceutical JSC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DHG Pharmaceutical JSC Stock Events
Event | Date | Price(â‚«) | ||
---|---|---|---|---|
No Event Data |
DHG Pharmaceutical JSC Frequently Asked Questions
What is DHG Pharmaceutical JSC(STC:DHG)'s stock price today?
The current price of STC:DHG is â‚«106400.00. The 52 week high of STC:DHG is â‚«125900.00 and 52 week low is â‚«95000.00.
When is next earnings date of DHG Pharmaceutical JSC(STC:DHG)?
The next earnings date of DHG Pharmaceutical JSC(STC:DHG) is .
Does DHG Pharmaceutical JSC(STC:DHG) pay dividends? If so, how much?
The Dividend Yield %  of DHG Pharmaceutical JSC(STC:DHG) is 7.02% (As of Today), Highest Dividend Payout Ratio of DHG Pharmaceutical JSC(STC:DHG) was 1.12. The lowest was 0.25. And the median was 0.52. The  Forward Dividend Yield % of DHG Pharmaceutical JSC(STC:DHG) is 7.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |